Andrew L. Pecora, Director at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 48,654 shares at $7.00 ($228K) on 2013-12-17, disclosed to the SEC on 2013-12-19.
Open-market purchase of $228k TLOG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 16,055 | $0 | 0.0% |
| 2 | $6.40 | 161 | $1K | 0.5% |
| 3 | $7.00 | 5,887 | $41K | 18.1% |
| 4 | $7.00 | 26,551 | $186K | 81.5% |
| Total | $4.69 avg | 48,654 | $228K | 100% |
| Filing → |
| NBS | BUY | 2014-11-25 | $50K | — | Filing → |
| TLOG | BUY | 2014-11-19 | $91K | — | Filing → |
| CGIX | SELL | 2013-11-20 | $713K | — | Filing → |